LIVN Stock: Price, Earnings History and SEC Filings
LivaNova PLC (LIVN) last traded at $78.97, down 2.81% on the latest session and up 3.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.02 against an analyst estimate of $0.96, a beat of 6.3%.
$78.97 -2.81%
1 month+3.23%
52-week high$85.76
52-week low$48.82
Volume575,597
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LIVN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $1.02 | $0.96 | +6.25% |
| Mar 2026 | May 6, 2026 | $0.87 | $0.72 | +20.83% |
| Dec 2025 | Feb 25, 2026 | $0.73 | $0.67 | +8.96% |
| Sep 2025 | Nov 5, 2025 | $0.97 | $0.78 | +24.36% |
LIVN beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for LIVN
SEC filing data is not available right now. You can search for LIVN on SEC EDGAR.
LIVN news
- ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue EstimatesOct 28, 2026 · finance.yahoo.com
- Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant EpilepsyOct 23, 2026 · finance.yahoo.com
- LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in NovemberOct 21, 2026 · finance.yahoo.com
- Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of DirectorsOct 20, 2026 · finance.yahoo.com
About LivaNova PLC
LivaNova PLC (LIVN) is a US-listed public company on Nasdaq.